It was suggested that PAX2 and PAX5 play tumor suppressor roles in ovarian cancer and leukemia47,48, while conversely, PAX3, PAX7, and PAX6 were reported to be oncogenic in embryonal rhabdomyosarcomas and retinoblastoma49,50. The gene discussed is PAX3; the disease is ovarian carcinoma.